This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Deborah Sokol Ricci
Introduction
Deborah Sokol Ricci is a prominent inventor based in Ringoes, NJ (US). She has made significant contributions to the field of medical research, particularly in the area of cancer treatment. Her work focuses on improving patient outcomes through innovative methods and technologies.
Latest Patents
Deborah holds a patent for "Biological markers for identifying patients for treatment with abiraterone acetate." This patent outlines methods for predicting the likelihood of survival following treatment with abiraterone acetate and prednisone in patients diagnosed with castration-resistant prostate cancer (CRPC). This innovation is crucial for personalizing treatment plans and enhancing patient care.
Career Highlights
Deborah has had a successful career at Janssen Pharmaceutica NV, where she has been involved in groundbreaking research and development. Her expertise in the pharmaceutical industry has allowed her to contribute to advancements in cancer therapies and patient management.
Collaborations
Throughout her career, Deborah has collaborated with esteemed colleagues, including Weimin Li and Michael Gormley. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Deborah Sokol Ricci's work exemplifies the impact of innovation in the medical field. Her contributions to cancer treatment through her patented methods highlight the importance of research and collaboration in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
